… , impairment on QoL, complications of disease and therapy. Autoimmune Blistering Diseases
occurring in children can usually be managed with topical steroids with a good prognosis. …

… Eighty-nine percent of patients treated with rituximab and short-term prednisone were in
complete remission off therapy at 24 months, compared with 34% of patients treated with …

… corticosteroids15, 21 and sometimes, a second-line therapy … The use of oral corticosteroids
was less frequent in our study … pemphigus after failure of local corticosteroid (90% of patients…

… Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs).
The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based …

… Rituximab and oral corticosteroid therapy are safe and effective when used as first-line
treatments for pemphigus patients, according to additional research. Cho and colleagues …

… autoimmune blistering diseases by describing the mechanisms underpinning skin autoimmunity
and … Combining conventional systemic corticosteroids with rituximab treatment has also …

… of EBA from other pemphigoid diseases, given that it shows … , while all other pemphigoid
diseases present with an n-… is used in combination with systemic glucocorticoids (1 mg/kg …

… In pooled meta-analysis, autoimmune blistering disease patients … corticosteroid treatment
results in increased cardiovascular-related adverse events in autoimmune blistering disease…

… following cessation of the BA or systemic corticosteroids used to treat the AIBD. Five cases
rechallenged the patient with the involved BA and four of the five reported recurrence, often …

… and epidermolysis bullosa acquisita are subepidermal autoimmune blistering diseases …
with corticosteroids or immunomodulators may also be used. Systemic corticosteroid therapy …